Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)
Clinical trial NCT00135941 · COMPLETED
Trial details
- NCT number
- NCT00135941
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.